| __timestamp | Agios Pharmaceuticals, Inc. | United Therapeutics Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 100371000 | 242549000 |
| Thursday, January 1, 2015 | 141827000 | 245098000 |
| Friday, January 1, 2016 | 220163000 | 147600000 |
| Sunday, January 1, 2017 | 292681000 | 264600000 |
| Monday, January 1, 2018 | 341324000 | 357900000 |
| Tuesday, January 1, 2019 | 410894000 | 1182600000 |
| Wednesday, January 1, 2020 | 367470000 | 357700000 |
| Friday, January 1, 2021 | 256973000 | 540100000 |
| Saturday, January 1, 2022 | 279910000 | 322900000 |
| Sunday, January 1, 2023 | 288903000 | 408000000 |
| Monday, January 1, 2024 | 301286000 |
Unlocking the unknown
In the competitive world of biotechnology, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Over the past decade, United Therapeutics Corporation and Agios Pharmaceuticals, Inc. have demonstrated distinct strategies in their R&D allocations.
From 2014 to 2023, United Therapeutics consistently invested heavily in R&D, peaking in 2019 with a staggering 1.18 billion dollars, a 400% increase from its 2016 low. Meanwhile, Agios Pharmaceuticals showed a steady growth in R&D spending, reaching its zenith in 2019 with a 310% increase from 2014.
These trends highlight the dynamic nature of R&D investments in the biotech sector, reflecting each company's strategic priorities and market positioning. As the industry evolves, understanding these financial commitments offers valuable insights into future innovations and breakthroughs.
Analyzing R&D Budgets: Pfizer Inc. vs United Therapeutics Corporation
Regeneron Pharmaceuticals, Inc. vs Agios Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
United Therapeutics Corporation or Genmab A/S: Who Invests More in Innovation?
Research and Development: Comparing Key Metrics for United Therapeutics Corporation and Verona Pharma plc
Comparing Innovation Spending: United Therapeutics Corporation and Viking Therapeutics, Inc.
R&D Insights: How United Therapeutics Corporation and Catalyst Pharmaceuticals, Inc. Allocate Funds
Research and Development: Comparing Key Metrics for United Therapeutics Corporation and Novavax, Inc.
Analyzing R&D Budgets: Dr. Reddy's Laboratories Limited vs Agios Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: ADMA Biologics, Inc. vs Agios Pharmaceuticals, Inc.
R&D Insights: How Amneal Pharmaceuticals, Inc. and Agios Pharmaceuticals, Inc. Allocate Funds
Comparing Innovation Spending: Protagonist Therapeutics, Inc. and Agios Pharmaceuticals, Inc.
Comparing Innovation Spending: Agios Pharmaceuticals, Inc. and Xencor, Inc.